Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 4Unknown 2Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Breast 2Other 1

Conditions

Breast Neoplasms 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Trastuzumab 25Carboplatin 20Paclitaxel 19pertuzumab 18pyrotinib 17Cyclophosphamide 17Capecitabine 16trastuzumab deruxtecan 15Docetaxel 15Radiotherapy 13Standard of Care 12Fulvestrant 12Drug Therapy 12dalpiciclib 11Letrozole 11pembrolizumab 9Epirubicin 9sacituzumab govitecan 8palbociclib 8exemestane 8eribulin 8Anastrozole 8Injections 7Doxorubicin 7130-nm albumin-bound paclitaxel 7toripalimab 6abemaciclib 6Tamoxifen 6Specimen Handling 6Neoadjuvant Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Megestrol Acetate × Breast × Clear all
NCT07543536 2026-04-22

MEGA-TACT-BC3

Sun Yat-sen University

Phase 3 Not yet recruiting
132 enrolled
Breast

Breast Neoplasms

NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
120 enrolled
Breast

Breast Cancer Patients Treated With T-DXd

Data powered by HemOnc (CC BY 4.0) Colophon âš¡